Comparing fetal scalp lactate and umbilical cord arterial blood gas values

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 54, Issue 1, 2014, Pages 79-83

  Bowler, Thea ^a   Beckmann, Michael ^a,b,c  

^a Mater Health Services   (Australia)

^b Mater Research   (Australia)

^c MATER MOTHERS HOSPITAL   (Australia)

Author keywords

abnormal fetal heart rate; fetal acidaemia; fetal scalp blood microsampling; labour; lactate; metabolic acidosis

Indexed keywords

LACTIC ACID;

ARTERIAL GAS; ARTERIAL PH; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; DELIVERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FETAL SCALP LACTATE; FETUS; FETUS BLOOD SAMPLING; HUMAN; HUMAN EXPERIMENT; HYPOXIA; LABOR; PREDICTIVE VALUE; PRIORITY JOURNAL; SCALP; SENSITIVITY AND SPECIFICITY; TERM BIRTH; UMBILICAL ARTERY; UMBILICAL CORD BLOOD;

ABNORMAL FETAL HEART RATE; FETAL ACIDAEMIA; FETAL SCALP BLOOD MICROSAMPLING; LABOUR; LACTATE; METABOLIC ACIDOSIS;

ACIDOSIS; BLOOD GAS ANALYSIS; FEMALE; FETAL BLOOD; FETAL MONITORING; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT, NEWBORN; LABOR, OBSTETRIC; LACTIC ACID; PREGNANCY; RETROSPECTIVE STUDIES; SCALP; SENSITIVITY AND SPECIFICITY;

EID: 84893350817     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/ajo.12144     Document Type: Article

References (21)

1. Royal College of Obstetricians and Gynaecologists. The use of Electronic Fetal Monitoring. The use and Interpretation of Cardiotocography in Intrapartum Fetal Surveillance. Evidence-based Clinical Guideline Number 8. London: RCOG Press, 2001.
2. Kruger K, Kublickas M, Westgren M,. Lactate in scalp and cord blood from fetuses with ominous fetal heart rate patterns. Obstet Gynecol 1998; 92: 918-922.
3. Umstad MP,. The predictive value of abnormal fetal heart rate patterns in early labour. Aust N Z J Obstet Gynaecol 1993; 33 (2): 145-149.
4. Goldaber KG, Gilstrap LC 3rd, Leveno KJ, et al,. Pathologic fetal acidemia. Obstet Gynecol 1991; 78: 1103-1107.
5. Yeh P, Emary K, Impey L,. The relationship between umbilical cord arterial pH and serious adverse neonatal outcome: analysis of 51 519 consecutive validated samples. BJOG 2012; 119: 824-831.
6. Maclennan A,. A Template for defining a causal relationship between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999; 319: 1054-1059.
7. East CE, Leader LR, Sheehan P, et al,. Intrapartum fetal scalp lactate sampling in the presence of a non-reassuring fetal heart rate trace. Cochrane Database Syst Rev 2010; 3: 1-27. Art. No. CD006174.
8. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Intrapartum Fetal Surveillance Clinical Guideline. Melbourne: RANZCOG, 2009.
9. Westgren M, Kruger K, Ek S, et al,. Lactate compared with pH analysis at fetal scalp blood sampling: a prospective randomised study. Br J Obstet Gynaecol 1998; 105: 29-33.
10. Allen RM, Bowling FG, Oats JJ,. Determining the fetal scalp lactate level that indicates the need for intervention in labour. Aust N Z J Obstet Gynaecol 2004; 44: 549-552.
11. Holzmann JM, Cnattingius S, Nordstrom L,. Outcome of severe intrapartum acidemia diagnosed with fetal scalp blood sampling. J Perinat Med 2011; 39: 545-548.
12. Ramanah R, Martin A, Clement MC, et al,. Fetal scalp lactate microsampling for non-reassuring fetal status during labour: a prospective observational study. Fetal Diagn Ther 2010; 27: 14-19.
13. Heinis AM, Spaanderman ME, Gunnewiek JM, Lotgering FK, et al,. Scalp blood lactate for intra-partum assessment of fetal metabolic acidosis. Acta Obstet Gynecol Scand 2011; 90: 1107-1114.
14. Kruger K, Hallberg B, Blennow M, et al,. Predictive value of fetal scalp blood lactate concentration and pH as markers of neurologic disability. Am J Obstet Gynecol 1999; 181: 1072-1078.
15. Wiberg-Itzel E, Lipponer C, Norman M, et al,. Determination of pH or lactate in fetal scalp blood in management of intrapartum fetal distress: randomised controlled multicentre trial. BMJ 2008; 336: 1284-1287.
16. Findlay G, Martin IC, Carter S, et al,. Trauma: who cares? A report of the National Confidential Enquiry into Patient Outcome and Death. National Confidential Enquiry into Patient Outcome and Death, November 2007. Available from www.ncepod.org.uk/2007t.htm.
17. Pasupathy D, Wood AM, Pell JP, et al,. Time of birth and risk of neonatal death at term: retrospective cohort study. BMJ 2010; 341: c3498.
18. National Institute for Health and Clinical Excellence. Intrapartum Care. Care of Healthy Women and Their Babies During Childbirth. NICE Clinical Guideline Number 55. London: NHS Evidence, 2007.
19. Riboni F, Vitulo A, Dell'avanzo M, et al,. Biochemical markers predicting pre-term delivery in symptomatic patients: phosphorylated insulin-like growth factor binding protein-1 and fetal fibronectin. Arch Gynecol Obstet 2011; 284 (6): 1325-1329.
20. Ting HS, Chin PS, Yeo GS, Kwek K,. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann Acad Med Singapore 2007; 36 (6): 399-402.
21. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Use of Cervical Fetal Fibronectin and Phosphorylated Insulin-Like Growth Factor Binding Protein 1 as Screening Tests for Preterm Birth. RANZCOG Clinical Guideline C-Obs 26. Melbourne: RANZCOG, 2011.